SG/CALL/ABBOTT LABORATORIES/140/0.1/20.06.25 Stock

Warrant

DE000SU6E3A8

Real-time Boerse Frankfurt Warrants 07:03:56 2024-05-16 am EDT
0.13 EUR -7.14% Intraday chart for SG/CALL/ABBOTT LABORATORIES/140/0.1/20.06.25
Current month-33.33%
1 month-57.58%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-16 0.13 -7.14%
24-05-15 0.14 +7.69%
24-05-14 0.13 -13.33%
24-05-13 0.15 -6.25%
24-05-10 0.16 +6.67%

Real-time Boerse Frankfurt Warrants

Last update May 16, 2024 at 07:03 am EDT

More quotes

Static data

Product typeWarrant Plain-Vanilla
Buy / SellCALL
Underlying ABBOTT LABORATORIES
IssuerLogo Issuer Société Générale Société Générale
WKN SU6E3A
ISINDE000SU6E3A8
Date issued 2023-12-29
Strike 140 $
Maturity 2025-06-20 (401 Days)
Parity 10 : 1
Emission price 0.39
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.69
Lowest since issue 0.13
Spread 0.02
Spread %13.33%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
104.6 USD
Average target price
126.1 USD
Spread / Average Target
+20.61%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW